5-FU/L-FU
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 5-FU/L-FU, covering 2020-07-14 to 2020-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer [Phase 3]